Menu
Not yet recruiting NCT07048080

Prehabilitation in Older People Undergoing Total Hip Replacement

No phase Interventional Hip Replacement in Osteoarthritis Patients Osteoarthritis, Hip

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: (P)rehabilitation Progresive Resistance Exercise Training, Prehabilitation Group Deuterated Water, Usual Care Group Deuterated Water, Usual Care.
Who it may be relevant to
Registry conditions: Hip Replacement in Osteoarthritis Patients, Osteoarthritis, Hip. Basic parameters: from 60 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Chile
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

(P)Rehabilitation in Older People With Osteoarthritis Undergoing Total Hip Replacement : From Physicological Mechanism to Clinical Benefits

Overview

The goal of this clinical trial is to determine the effect of Resistance Exercise Training (RET)-based (p)rehabilitation versus usual care on skeletal muscle mass and function, as well as on underlying biological processes, in older adults undergoing elective Total Hip Replacement (THR) due to severe Osteoarthritis (OA). The main questions it aims to answer are: * What is the effects of RET-based (p)rehabilitation versus usual care to improve muscle mass and function in patients undergoing elective unilateral THR surgery for end-stage OA? * What is the potential of certain circulating biomarkers to predict the efficacy of the musculoskeletal system response to RET in patients with severe OA? Researchers will compare RET-based (p)rehabilitation versus usual care to see if RET works to increase skeletal muscle mass and function. Participants in the usual care group will undergo standard rehabilitation (12 weeks post-surgery), and participants in the (p)rehabilitation group will undergo RET-based full-body (p)rehabilitation (3x/week) for 2 weeks pre-surgery and 12 weeks post-surgery.

Detailed description

Introduction: Due to age, patients suffering from osteoarthritis (OA) experience a loss of skeletal muscle mass, strength, and functional capacity both before and after total hip arthroplasty (THA). Progressive resistance exercise training (RET) is a safe and feasible intervention before and after THA. However, the physiological and clinical effects have not been investigated on a larger scale.

Objectives: To determine the effect of RET-based (p)rehabilitation versus usual care on skeletal muscle mass and function, as well as on underlying biological processes, in older adults undergoing elective THA due to severe OA.

Materials and Methods: Seventy older adults scheduled for elective unilateral THA due to severe primary OA (usual care group: n=35, ≥60 years; (p)rehabilitation group: n=35, ≥60 years) will be included in this single-blind randomized controlled trial. Participants in the usual care group will undergo standard rehabilitation (12 weeks post-surgery), and participants in the (p)rehabilitation group will undergo RET-based full-body (p)rehabilitation (3x/week) for 2 weeks pre-surgery and 12 weeks post-surgery. MRI scans of the thigh will be taken at baseline, 24 hours before, and 12 weeks after surgery to assess the cross-sectional area of the quadriceps. On the same days, blood and muscle samples will be collected, and dual-energy X-ray absorptiometry (DEXA) will be performed. Maximum strength, muscle function/morphology, physical capacity, quality of life, performance in activities of daily living, physical activity level, hip function, nutritional status, and cognitive status will also be assessed. The occurrence of serious adverse events, hospital readmissions, infections, and complications will be considered.

In a sub-study, 20 participants (n=10 from the usual care group and n=10 from the (p)rehabilitation group) will be included to investigate the effects of 2 weeks of (p)rehabilitation on tissue protein synthesis rates. A 2-week deuterium oxide (²H₂O or "heavy water") loading protocol will be implemented in both groups during the two weeks prior to THA to assess musculoskeletal tissue protein synthesis rates. This method allows for the evaluation of the protein synthesis rate in muscle, cartilage, and bone tissue when samples are collected two weeks after the (p)rehabilitation or usual care interventions. These tissues will be collected during surgery, so no additional procedures are required from participants. In addition to determining the effects of RET on protein synthesis rates in tissues relevant to musculoskeletal health, the association between protein synthesis rates and long-term clinical outcomes will also be explored.

Expected Results: It is hypothesized that 14 weeks (2 weeks pre- and 12 weeks post-surgery) of progressive RET-based (p)rehabilitation will increase muscle mass and function to a greater extent than usual care, which is based on mobility and strength exercises without progressive machine-based RET. Additionally, RET will induce an increase in protein synthesis rates in muscle, cartilage, and bone tissues through the activation/inhibition of established signaling pathway markers (Akt, mTOR, S6(K), 4E-BP1, MAFbx, MuRF1). Furthermore, it is hypothesized that the increase in protein synthesis rate in these tissues will be associated with specific circulating biomarkers of musculoskeletal health (including CTX-II, COMP, CTX-I, OC, PIIINP, S1) and will indicate gains in muscle mass and functional improvements in the progressive RET group compared to the usual care group.

These findings will define the efficacy of progressive RET-based rehabilitation in increasing muscle mass and clinical outcomes in older adults with severe hip OA undergoing THA. Better maintenance or even increases in muscle mass and strength enhance independence, prolong health, aid recovery from illness, and reduce the burden on healthcare services. This information will have a beneficial impact on the fields of exercise physiology, orthopedics, and aging for future interventions at local, regional, national, and international levels.

Interventions

  • Behavioral (P)rehabilitation Progresive Resistance Exercise Training
    The (p)rehabilitation intervention program will be based on supervised whole-body RET performed 3 times/week before (2-week) and up to 12 weeks after surgery, with one day in-between sessions. Training will consist of a 10-min warm-up, followed by one warm-up and 4 sets on leg press, leg-extension and leg abductor machines. Upper body exercises (chest press, lat pulldown and horizontal row will be performed with 2 sets of each exercise. During the 2-week training before surgery, the workload wil
  • Biological Prehabilitation Group Deuterated Water
    In a sub-study, the first 10 participants of the (P)rehabilitation group will be included to study the effects of 2 weeks prehabilitation on tissue protein synthesis rates. A two-week deuterium oxide (2H2O or 'heavy water') loading protocol will be conducted during the two week before THR surgery to assess diurnal rates of musculoskeletal protein synthesis. This 2H2O method enables the assessment of muscle, cartilage and bone tissue protein synthesis rates when tissue samples are collected after
  • Biological Usual Care Group Deuterated Water
    In a sub-study, the first 10 participants of the Usual Care group will be included to study the effects of 2 weeks prehabilitation on tissue protein synthesis rates. A two-week deuterium oxide (2H2O or 'heavy water') loading protocol will be conducted during the two week before THR surgery to assess diurnal rates of musculoskeletal protein synthesis. This 2H2O method enables the assessment of muscle, cartilage and bone tissue protein synthesis rates when tissue samples are collected after the 2
  • Other Usual Care
    Participants assigned to the usual care group will receive the usual therapy, medical monitoring, and educational lectures after surgery. No intervention is planned before total hip replacement surgery. The patient is hospitalized for surgery. At hospital discharge, the usual care group will start with standard rehabilitation (sessions: 1st month, 2-3x/week, 2nd month 1-2x/week and 3rd month 1x/month) based on mobility and strength exercises without using progressive RET with machines until 3 mo

Primary outcome measures

  • Change in Cross-Sectional Area of Quadriceps measured via MRI - Scanning after resistance exercise training [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention in both groups]
  • Change in Protein Synthesis Rates (MPS) on Muscle, Bone and Cartilage measured via tissue samples after resistance exercise training. [Time frame: The assessment will be conducted 2 weeks before surgery and during the surgery.]
Secondary outcome measures (12)
  • Change in functional capacity measured via Short Physical Performance Battery (SPPB) after resistance exercise training. [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention.]
  • Immunodetection of protein synthesis markers in tissue sample 2 weeks before surgery, during surgery and after resistance exercise training. [Time frame: The assessments will be conducted with the samples obtained 2 weeks before surgery, during surgery and after 12-week intervention.]
  • Change in biomarkers measured via blood samples after resistance exercise training. [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention.]
  • Change in functional capacity measured via Timed Up and Go test (TUG) after resistance exercise training. [Time frame: The assessment will be conducted 2 weeks and 48 hours before and after the 12-week intervention]
  • Change in muscle strength measured via 1RM strength tests after resistance exercise training. [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention]
  • Change in body composition measured via dual-energy X-ray absorptiometry scanning after resistance exercise training [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention]
  • Change in quality of life measured via SF-36 scale after resistance exercise training. [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention.]
  • Change in Independence in Activities of Daily Living via Lawton and Brody questionnaire after resistance exercise training. [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention.]
  • Change in Cognitive Function measured via MoCA questionnaire after resistance exercise training. [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention.]
  • Change in Nutritional Status measured via Mini Nutritional Assessment and Malnutrition Universal Screening Tool after resistance exercise training. [Time frame: The assessments will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention.]
  • Change in Perceived Hip Functionality measured via Harris Hip Score Questionnaire. [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after 12-week intervention.]
  • Change in habitual physical activity measured via Physical Activity Scale for Elderly (PASE) after resistance exercise training [Time frame: The assessment will be conducted 2 weeks and 48 hours before surgery and after the 12-week intervention.]

Eligibility criteria

Inclusion criteria

  • Individuals aged from 60 y and over.
  • 18.5 < BMI < 40 kg/m2.
  • Individuals on waiting list to undergo a unilateral elective surgery for Total Hip Replacement due to primary severe Osteoarthritis.

Exclusion criteria

  • Individuals with severe OA in the contralateral hip.
  • Individuals who has been performing regular RET (2 or more times per week) in the previous 6 months.
  • Individuals who smoke.
  • Significant psychiatric or neurological disorders, with the use of acetylcholinesterase inhibitors, and untreated mood disorders or depressive pathology.
  • Neuromuscular or mobility disorders that prevent safe resistance training (debilitating arthritis, spasticity/rigidity, and paralysis), along with untreated metabolic disorders (such as uncontrolled systemic hypertension).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Chile · 1 center
  • Universidad de La Frontera — Temuco

Identifiers

NCT: NCT07048080 · FONDECYT 1251133

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗